- Home
- THRD vs HTCO Comparison
THRD vs HTCO Comparison
Compare THRD & HTCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- THRD
- HTCO
- Stock Information
- Founded
- THRD 2019
- HTCO N/A
- Country
- THRD United States
- HTCO Hong Kong
- Employees
- THRD N/A
- HTCO N/A
- Industry
- THRD Biotechnology: Pharmaceutical Preparations
- HTCO
- Sector
- THRD Health Care
- HTCO
- Exchange
- THRD Nasdaq
- HTCO NYSE
- Market Cap
- THRD 335.2M
- HTCO 360.8M
- IPO Year
- THRD 2022
- HTCO N/A
- Fundamental
- Price
- THRD $3.47
- HTCO $2.94
- Analyst Decision
- THRD Buy
- HTCO
- Analyst Count
- THRD 3
- HTCO 0
- Target Price
- THRD $14.00
- HTCO N/A
- AVG Volume (30 Days)
- THRD 1.2M
- HTCO 88.1K
- Earning Date
- THRD 03-25-2025
- HTCO 01-01-0001
- Dividend Yield
- THRD N/A
- HTCO N/A
- EPS Growth
- THRD N/A
- HTCO N/A
- EPS
- THRD N/A
- HTCO N/A
- Revenue
- THRD N/A
- HTCO $80,567,672.00
- Revenue This Year
- THRD N/A
- HTCO N/A
- Revenue Next Year
- THRD N/A
- HTCO N/A
- P/E Ratio
- THRD N/A
- HTCO N/A
- Revenue Growth
- THRD N/A
- HTCO N/A
- 52 Week Low
- THRD $3.18
- HTCO $0.21
- 52 Week High
- THRD $16.94
- HTCO $4.50
- Technical
- Relative Strength Index (RSI)
- THRD 25.71
- HTCO N/A
- Support Level
- THRD $3.18
- HTCO N/A
- Resistance Level
- THRD $3.70
- HTCO N/A
- Average True Range (ATR)
- THRD 0.31
- HTCO 0.00
- MACD
- THRD 0.10
- HTCO 0.00
- Stochastic Oscillator
- THRD 13.26
- HTCO 0.00
About THRD Third Harmonic Bio Inc.
Third Harmonic Bio Inc is a biopharmaceutical company focused on the development of the next wave of medicine for the treatment of inflammatory diseases, including dermal, respiratory, and gastrointestinal diseases. The company's product candidate, THB001, is a selective, oral small-molecule inhibitor of KIT, a cell surface receptor that serves as the master regulator of mast cell function and survival. Its other product candidate THB335, is a potent, selective, oral small molecule KIT inhibitor, for the treatment of multiple mast cell-driven inflammatory diseases of the skin, airway, and gastrointestinal tract.
About HTCO CARAVELLE INTERNATIONAL GROUP
Caravelle International Group is an international operator of ocean transportation services. It is engaged in the seaborne transportation service under voyage contracts as well as vessel service for and on behalf of ship owners. The company has two operating segments namely, ocean transport and Heating business. The company derives the majority of its revenue from the Ocean transportation business. The company derives freight revenue from voyage contracts and provides vessel service.